Aschale Yibeltal, Tegegne Bantayehu Addis, Yihunie Wubetu
Department of Medical Laboratory Sciences, Debre Markos University, Debre Markos, Ethiopia.
Department of Pharmacy, Debre Markos University, Debre Markos, Ethiopia.
Hepat Med. 2023 Mar 9;15:11-19. doi: 10.2147/HMER.S402975. eCollection 2023.
Treatment of human and animal ailments using botanical sources has obtained significant attention in Ethiopia. The compounds available in plants comprise a plentiful source of bioactive ingredients able to treat many complications. The review aimed to present an updated list of plants used for managing hepatitis over the past 15 years in Ethiopia.
Systematic, comprehensive search was undertaken from electronic databases (PubMed, Google Scholar, Science Direct, and Scopus) between September 01 and October 15, 2022, using standard search terms. Original researches carried out in Ethiopia, written and published in English between January 01/2007 and December 31/2021, and reported hepatitis as a disease treated by medicinal plants were included in the review. Plants beyond the list of Ethiopian and Eritrean floral were excluded. Data were extracted from texts and tables of original papers on a Microsoft Excel. Quality was assessed by applying the Joanna Briggs Institute Critical Appraisal Checklist.
A total of 317 papers were obtained from the database search. After removing duplicates and screening, 15 articles fit the inclusion criteria and selected for final review. Of the 24 plants identified, 35.7% were herbs. Leaf and root (35.7% each) were the predominant plant parts used for remedy preparation. Combined use of leaf and root comprised 10.7%. The families Apocynaceae, , Cucurbitaceae, and Fabaceae comprise the highest number of plant species. About 89.3% of remedies were administered orally.
The majority of plants belong to herbs and the frequently used plant parts are leaf and roots. Evidence generated from the present review indicated that lots of plants have been used to manage hepatitis. Moreover, the findings could serve as preliminary information to formulate new drugs acting against hepatitis. Therefore, it is desirable for scholars to recognize, document, and keep plants and the associated knowledge appropriately.
在埃塞俄比亚,利用植物来源治疗人类和动物疾病已受到广泛关注。植物中含有的化合物是丰富的生物活性成分来源,能够治疗多种疾病。本综述旨在列出埃塞俄比亚过去15年用于治疗肝炎的植物的最新清单。
于2022年9月1日至10月15日期间,使用标准检索词从电子数据库(PubMed、谷歌学术、科学Direct和Scopus)进行系统、全面的检索。纳入本综述的研究为2007年1月1日至2021年12月31日期间在埃塞俄比亚开展、以英文撰写和发表、且报道了药用植物治疗肝炎的原始研究。埃塞俄比亚和厄立特里亚植物区系以外的植物被排除。数据从原始论文的文本和表格中提取到Microsoft Excel中。采用乔安娜·布里格斯研究所批判性评价清单进行质量评估。
通过数据库检索共获得317篇论文。去除重复项并筛选后,有15篇文章符合纳入标准并被选入最终综述。在确定的24种植物中,35.7%为草本植物。叶和根(各占35.7%)是用于制备药物的主要植物部位。叶和根联合使用的占10.7%。夹竹桃科、葫芦科和豆科包含的植物种类最多。约89.3%的药物通过口服给药。
大多数植物属于草本植物,常用的植物部位是叶和根。本综述得出的证据表明,许多植物已被用于治疗肝炎。此外,这些发现可为研发抗肝炎新药提供初步信息。因此,学者们应适当地识别、记录和保存植物及其相关知识。